Skip to main content
HealthUnknownMedium
4.8

Roche expands China cancer R&D pact with Hansoh, potential $15B+ deal

Roche and Hansoh Pharmaceutical expanded their collaboration on early-stage cancer programs in a deal potentially worth over $15 billion plus royalties. This continues the trend of Western pharma tapping Chinese biotech innovation, though financial details and program specifics remain undisclosed.

Dagens Industri1 day agoCH, US, CNCredibility 28%View source

Score Breakdown

Mosaic Score4.8
Model confidence0.5
Significance0.5
Source credibility0.3

Intelligence Tags

Entities

United StatescountryChinacountrySwitzerlandcountry
Source

Related signals

8 found